Atlas Trials

Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas

Clinical trial NCT02776163 · COMPLETED

Trial details

NCT number
NCT02776163
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Salivary Gland TumorsHead and Neck Cancer
Start date
2016-06-01
Primary completion
2022-12-31
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.